CDKN2B and ovarian carcinoma: For example, Dunfield and Nachtigal reported that in primary human ovarian cancer cells, EGF decreased the TGFβ-induced mRNA expression of the cell cycle regulator, p15INK4B, thus decreasing the sensitivity of the ovarian cancer cells to the anti-proliferative effect of TGFβ25.